Request to attend: Future of Healthcare Investor Forum

Thursday 25 January 2018

London Stock Exchange and MedCity are proud to host the 4rd Annual Future of Healthcare Investor Forum on 25 January 2018 at London Stock Exchange, 10 Paternoster Square, London, EC4M 7LS.

The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the direction of leading technologies and investment for the future.

This invitation-only, free to attend conference will showcase leading public and private UK life sciences companies through a series of short presentations and themed panel sessions covering innovation in areas such as Lifesciences business models, Respiratory therapies and for the first time, Digital Health. Once again we will pay host to host leading industry experts and feature key representatives of Astra Zeneca, Syncona, Abcam, Vectura, Circassia, Maxcyte, GSK and many others.

We will keep you updated as the agenda is finalised and as new speakers are confirmed.

Venue
London Stock Exchange
10 Paternoster Square
London EC4M 7LS

Registration
0830 - please bring photo ID

Timings
0900 - 1400


Kind regards,

James Clark
Primary Markets, Tech & Life-Sciences
London Stock Exchange

Request to attend

If you indicate that you wish to subscribe to marketing communications, either by submitting a dedicated subscription form and/or selecting a relevant subscription option on a form, you consent to receiving email communications from London Stock Exchange Group plc and the London Stock Exchange Group of companies (together, LSEG). LSEG will update your email preferences and hold your details in its contact database which can be accessed by LSEG group companies. For more information on how LSEG uses your data, see our Privacy Policy. For more information about LSEG group companies, click here. You can update your email preferences or unsubscribe at any time by clicking here.